Recordati S.p.A. logo

Recordati S.p.A.

Stock
Stock
ISIN: IT0003828271
Ticker: REC
IT0003828271
REC

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

 The next dividend will be paid on 21.05.2026


€0.636

CHART BY

Frequently asked questions

What is Recordati S.p.A.'s market capitalization?

The market capitalization of Recordati S.p.A. is €9.81B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Recordati S.p.A.'s Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Recordati S.p.A. is 22.61. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Recordati S.p.A.?

Recordati S.p.A.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is €2.146. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Recordati S.p.A.'s stock?

Currently, 13 analysts cover Recordati S.p.A.'s stock, with a consensus target price of €58.96. Analyst ratings provide insights into the stock's expected performance.

What is Recordati S.p.A.'s revenue over the trailing twelve months?

Over the trailing twelve months, Recordati S.p.A. reported a revenue of €2.62B.

What is the free float of Recordati S.p.A.'s shares?

The free float of Recordati S.p.A. is 105.73M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
€9.81B
EPS (TTM) 
€2.146
Free Float 
105.73M
P/E ratio (TTM) 
22.61
Revenue (TTM) 
€2.62B

Pricing

1D span
€47.78€48.39
52W span
€43.98€55.35

Analyst Ratings

The price target is €58.96 and the stock is covered by 13 analysts.

Buy

7

Hold

6

Sell

0

Information

Recordati SpA engages in the research, development, manufacture, and marketing of pharmaceuticals. It operates through the Specialty and Primary Care, and Rare Diseases segments. The Specialty and Primary Care segment includes pharmaceutical chemical operations. The company was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.

Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
IT0003828271
Primary Ticker
REC

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation